Literature DB >> 15173257

Improved biomarkers for prostate cancer: a definite need.

H Ballentine Carter, William B Isaacs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173257     DOI: 10.1093/jnci/djh174

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  10 in total

1.  Translation research in prostate cancer.

Authors:  Danil V Makarov; Alan W Partin
Journal:  Rev Urol       Date:  2006

2.  Ultrasensitive immunosensor for cancer biomarker proteins using gold nanoparticle film electrodes and multienzyme-particle amplification.

Authors:  Vigneshwaran Mani; Bhaskara V Chikkaveeraiah; Vyomesh Patel; J Silvio Gutkind; James F Rusling
Journal:  ACS Nano       Date:  2009-03-24       Impact factor: 15.881

3.  The significance of monoamine oxidase-A expression in high grade prostate cancer.

Authors:  Donna M Peehl; Marc Coram; Htet Khine; Stephen Reese; Rosalie Nolley; Hongjuan Zhao
Journal:  J Urol       Date:  2008-09-20       Impact factor: 7.450

4.  Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer.

Authors:  Hatem Abou-Ouf; Mohammed Alshalalfa; Mandeep Takhar; Nicholas Erho; Bryan Donnelly; Elai Davicioni; R Jeffrey Karnes; Tarek A Bismar
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-06       Impact factor: 4.553

5.  Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.

Authors:  Heather Orom; D Lynn Homish; Gregory G Homish; Willie Underwood
Journal:  Urol Oncol       Date:  2013-12-12       Impact factor: 3.498

6.  New serum biomarkers for prostate cancer diagnosis.

Authors:  Kailash C Chadha; Austin Miller; Bindukumar B Nair; Stanley A Schwartz; Donald L Trump; Willie Underwood
Journal:  Clin Cancer Investig J       Date:  2014

7.  Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer.

Authors:  M Schostak; H Krause; K Miller; M Schrader; S Weikert; F Christoph; C Kempkensteffen; J Kollermann
Journal:  BMC Urol       Date:  2006-03-15       Impact factor: 2.264

8.  Can p503s, p504s and p510s gene expression in peripheral-blood be useful as a marker of prostatic cancer?

Authors:  Maria Rosaria Cardillo; Vincenzo Gentile; Antonio Ceccariello; Laura Giacomelli; Stefano Messinetti; Franco Di Silverio
Journal:  BMC Cancer       Date:  2005-09-05       Impact factor: 4.430

9.  The expressions of AMACR and iNOS in prostate adenocarcinomas.

Authors:  Tumay Ozgur; Esin Atik; Sibel Hakverdi; Mehmet Yaldiz
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

Review 10.  Current early diagnostic biomarkers of prostate cancer.

Authors:  Min Qu; Shan-Cheng Ren; Ying-Hao Sun
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.